BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 3890661)

  • 1. [Stages of the etiological diagnosis of hypercalcemia].
    Fournier A; Sebert JL; Makdassi R
    Ann Med Interne (Paris); 1985; 136(1):49-58. PubMed ID: 3890661
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Non-neoplastic hypercalcemia].
    Bernadet P; Tremollières F; Durand D; Ton That H; Suc JM
    Rev Prat; 1989 Apr; 39(11):932-5. PubMed ID: 2717864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Diagnostic evaluation and differential diagnosis of primary hyperparathyroidism].
    Quesada Gómez JM
    Endocrinol Nutr; 2009 Apr; 56 Suppl 1():14-9. PubMed ID: 19627756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Etiologic diagnosis of hypercalcemia. A study of 100 cases].
    Dupont P; Fuss M; Corvilain J
    Rev Rhum Mal Osteoartic; 1978; 45(7-9):491-7. PubMed ID: 725466
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Approach to examining hypercalcemia in the clinical laboratory].
    Shirata T; Fukuyama H; Miura H; Suwabe A; Tominaga M
    Rinsho Byori; 1999 Dec; 47(12):1140-7. PubMed ID: 10639824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preoperative normal level of parathyroid hormone signifies an early and mild form of primary hyperparathyroidism.
    Bergenfelz A; Lindblom P; Lindergård B; Valdemarsson S; Westerdahl J
    World J Surg; 2003 Apr; 27(4):481-5. PubMed ID: 12658497
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical significance of asymptomatic hypercalcemia].
    Koller M
    Schweiz Med Wochenschr; 1985 May; 115(21):733-7. PubMed ID: 4012249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hypercalcemia in hospitalized patients. Diagnostic and prognostic aspects].
    Burkhardt E; Kistler HJ
    Schweiz Med Wochenschr; 1981 Dec; 111(51):2017-23. PubMed ID: 7313656
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unusual causes of hypercalcemia.
    Pont A
    Endocrinol Metab Clin North Am; 1989 Sep; 18(3):753-64. PubMed ID: 2673771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discriminative power of three indices of renal calcium excretion for the distinction between familial hypocalciuric hypercalcaemia and primary hyperparathyroidism: a follow-up study on methods.
    Christensen SE; Nissen PH; Vestergaard P; Heickendorff L; Brixen K; Mosekilde L
    Clin Endocrinol (Oxf); 2008 Nov; 69(5):713-20. PubMed ID: 18410554
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hypercalcemia as incidental finding--what should be done?].
    Burckhardt P
    Schweiz Rundsch Med Prax; 1994 Jan; 83(3):75-8. PubMed ID: 8296134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Laboratory screening for hyperparathyroidism.
    Younes NA; Shafagoj Y; Khatib F; Ababneh M
    Clin Chim Acta; 2005 Mar; 353(1-2):1-12. PubMed ID: 15698586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypercalcemia: an evidence-based approach to clinical cases.
    Assadi F
    Iran J Kidney Dis; 2009 Apr; 3(2):71-9. PubMed ID: 19395781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of C-terminal parathyroid assays in a large metropolitan hospital.
    Lum G
    Ann Clin Lab Sci; 1985; 15(1):55-60. PubMed ID: 3970518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypercalcemia of malignancy: a study of clinical features and relationships among circulating levels of calcium, parathyroid hormone and parathyroid hormone-related peptide.
    Sriussadaporn S; Phoojaroenchanachai M; Ploybutr S; Plengvidhya N; Peerapatdit T; Nitiyanant W; Vannasaeng S; Vichayanrat A
    J Med Assoc Thai; 2007 Apr; 90(4):663-71. PubMed ID: 17487119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The clinical utility of parathyroid hormone-related peptide in the assessment of hypercalcemia.
    Fritchie K; Zedek D; Grenache DG
    Clin Chim Acta; 2009 Apr; 402(1-2):146-9. PubMed ID: 19168044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Normocalcemic, subclinical, asymptomatic primary hyperparathyroidism in patients with goiter or papillary thyroid cancer--preliminary report. Normocalcemic primary hyperparathyroidism and thyroid pathology.
    Niedźwiecki S; Kuzdak K; Kaczka K; Pomorski L
    Wiad Lek; 2007; 60(5-6):228-30. PubMed ID: 17966885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blood coagulation, fibrinolysis and lipid profile in patients with primary hyperparathyroidism: increased plasma factor VII and X activities and D-Dimer levels.
    Erem C; Kocak M; Hacihasanoglu A; Yilmaz M; Saglam F; Ersoz HO
    Exp Clin Endocrinol Diabetes; 2008 Nov; 116(10):619-24. PubMed ID: 18484067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High prevalence of normal total calcium and intact PTH in 60 patients with proven primary hyperparathyroidism: a challenge to current diagnostic criteria.
    Glendenning P; Gutteridge DH; Retallack RW; Stuckey BG; Kermode DG; Kent GN
    Aust N Z J Med; 1998 Apr; 28(2):173-8. PubMed ID: 9612524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.